Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Plasma gene detection kit for early diagnosis of laryngeal squamous cell carcinoma (LSCC)

A technique for early diagnosis of squamous cell carcinoma, applied in the determination/testing of microorganisms, DNA/RNA fragments, recombinant DNA technology, etc.

Inactive Publication Date: 2018-11-02
邱长友
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] Currently there is no effective gene detection kit for early diagnosis of laryngeal squamous cell carcinoma

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Plasma gene detection kit for early diagnosis of laryngeal squamous cell carcinoma (LSCC)
  • Plasma gene detection kit for early diagnosis of laryngeal squamous cell carcinoma (LSCC)
  • Plasma gene detection kit for early diagnosis of laryngeal squamous cell carcinoma (LSCC)

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] Example 1: Preliminary verification of the diagnostic efficacy of miRNA markers for LSCC

[0026] 1. Subjects

[0027] This study included 75 newly diagnosed LSCC patients diagnosed by WHO histopathology in Jiangsu Provincial People's Hospital from June 2015 to June 2017. LSCC patients with other tumors or acute infections were excluded. Among the patients, there were 45 males and 30 females. At the same time, 75 age- and gender-matched healthy people who underwent physical examination at the Health Examination Center of Jiangsu Provincial People's Hospital were included as controls, including 45 males and 30 females, and there was no statistical difference in age from LSCC patients.

[0028] 2. Experimental method

[0029] 1. Plasma collection

[0030] Collect 2ml of venous blood and place it in an anticoagulant tube treated with dipotassium ethylenediaminetetraacetic acid. After anticoagulant treatment, divide it into a 2ml enzyme-free centrifuge tube, centrifuge ...

Embodiment 2

[0057] Example 2: Further multi-center validation of miRNA markers for LSCC diagnostic efficacy

[0058] 1. Subjects

[0059] This study included 48 newly diagnosed LSCC patients diagnosed by WHO histopathology in the Affiliated Hospital of Southwest Medical University from June 2015 to June 2017. LSCC patients with other tumors or acute infections were excluded. Among the patients, there were 30 males and 18 females. At the same time, 48 age- and sex-matched healthy people who underwent physical examination at the Health Examination Center of the Affiliated Hospital of Southwest Medical University were included as controls, including 30 males and 18 females, and there was no statistical difference in age from LSCC patients.

[0060] 2. Experimental methods and results

[0061] 1. Plasma collection

[0062] Collect 2ml of venous blood and place it in an anticoagulant tube treated with dipotassium ethylenediaminetetraacetic acid. After anticoagulant treatment, divide it int...

Embodiment 3

[0078] Embodiment 3: LSCC diagnostic kit

[0079] The LSCC diagnostic kit can contain the detection of hsa-miR-544a, hsa-miR-4726 and hsa-miR-135a-5p, or the detection of hsa-miR-544a, hsa-miR-4726 and hsa-miR-2278, or the detection of Primers for hsa-miR-544a, hsa-miR-636 and hsa-miR-597-5p also contain internal references and enzymes and reagents required for RT-PCR.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a plasma gene detection kit for early diagnosis of laryngeal squamous cell carcinoma (LSCC). By adopting the plasma gene detection kit, the accuracy of combined prediction of the LSCC with has-miR-544a, has-miR-4726 and hsa-miR-135a-5p is found to be 91.67% (88 / 96); the accuracy of combined prediction of the LSCC with hsa-miR-544a, hsa-miR-4726 and hsa-miR-2278 is 90.63% (87 / 96); and the accuracy of combined prediction of the LSCC with hsa-miR-544a, hsa-miR-636 and hsa-miR-597-5p is 94.79% (91 / 96), and the diagnostic accuracy is high.

Description

technical field [0001] The invention belongs to the field of gene detection and relates to a blood plasma gene detection kit for early diagnosis of laryngeal squamous cell carcinoma. Background technique [0002] Head and neck cancer is the sixth most common tumor type in the world, among which laryngeal cancer is one of the most common malignant tumors of the head and neck, and laryngeal squamous cell carcinoma (LSCC) is the most common histological type in laryngeal cancer (approx. 85% to 90%). With the development of medicine, there are more and more treatment methods for laryngeal cancer, but the mortality rate of laryngeal cancer has not improved significantly. The main reason is that there is currently a lack of simple and applicable screening methods. [0003] MicroRNA (microRNA, miRNA) refers to the endogenous small non-coding RNA with a length of about 22 nucleotides, which is an effective regulator of various biological processes. Studies on miRNA have shown that...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/6886C12N15/11
CPCC12Q1/6886C12Q2600/178
Inventor 邱长友葛孝锦罗彬瑞
Owner 邱长友
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com